Patent details

300622 Product Name: Nepafenac

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300622
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0999825
Status:
Renounced Art. 14 (b) of the EC Regulations
Application number:
300622
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/07/433/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
03/05/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
04/11/2013
First Marketing Authorization date:
03/05/2013
Grant date:
30/01/2014
Activation date:
17/07/2018
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
30/01/2014
NullificationDate:
Registration date:
04/11/2013
SPC/SPC Extension Expiration Date:
16/07/2023
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
14/01/2020
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Historical Applicant/holder

From:
14/01/2020
To:
14/01/2020

 

Name:
ALCON VISION, LLC
Address:
6201 South Freeway, 76134, Fort Worth, TX, United States of America (US)

From:
04/11/2013
To:
14/01/2020

 

Name:
ALCON LABORATORIES, INC
Address:
6201 South Freeway Mail Code Q-148, 76134-2099, Fort Worth, Texas, United States of America (US)

Agent

Name:
ir. J.C. Volmer c.s.
From:
04/11/2013
Address:
Exter Polak & Charlouis B.V. Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
50/20
Publication date:
09/12/2020
Description:
Lapse or annulment

2

Bulletin Heading:
MED
Journal edition number:
50/20
Publication date:
09/12/2020
Description:
Other communications

3

Bulletin Heading:
CO
Journal edition number:
04/20
Publication date:
22/01/2020
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
CO
Journal edition number:
04/20
Publication date:
22/01/2020
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
SPC
Journal edition number:
30/18
Publication date:
18/07/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

6

Bulletin Heading:
SPC
Journal edition number:
2014/06
Publication date:
06/02/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

7

Bulletin Heading:
SPC
Journal edition number:
2013/46
Publication date:
13/11/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Surrender

Change Kind/ Decision Type:
Total - Renunciation
Deed Number:
RC202002245A
Date Registered:
12/11/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.C. Volmer c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202000095A
Date Registered:
14/01/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
ALCON VISION, LLC
Address:
6201 South Freeway, 76134, Fort Worth, TX, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202000095B
Date Registered:
14/01/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2021
Annual Fee Number:
24
Annual Fee Amount:
2200 Euro
Last Annual Payment Date:
22/06/2020
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
17/09/2020 SPC Documents SPC Documents 1 PDF /2/2/6/0/0/0400300622/docs/300622_5_supplprotectioncertificate20200917025233616.pdf
30/01/2014 SPC Documents Certificate SPC 1 PDF /2/2/6/0/0/0400300622/docs/300622_4_supplprotectioncertificate20210223030657638.pdf
30/01/2014 Outgoing Correspondence Outgoing Letter 1 PDF /2/2/6/0/0/0400300622/docs/300622_6_outgoingcorrespondence20140130.pdf
04/11/2013 SPC Documents Marketing Authorization SPC 3 PDF /2/2/6/0/0/0400300622/docs/300622_0_supplprotectioncertificate20210223030051955.pdf
04/11/2013 Application Form First filed application form 2 PDF /2/2/6/0/0/0400300622/docs/300622_1_applicationform20131104.pdf
04/11/2013 SPC Documents Accompanying letter SPC 1 PDF /2/2/6/0/0/0400300622/docs/300622_2_supplprotectioncertificate20210223025727393.pdf
04/11/2013 SPC Documents Summary of the characteristics of the product 9 PDF /2/2/6/0/0/0400300622/docs/300622_3_supplprotectioncertificate20210223025541542.pdf